I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a deep understanding of technology and innovation in the industry, has positioned him as a leading voice in cancer research. Today, we’ll dive into his
In the fast-paced realm of healthcare innovation, a remarkable partnership between Singapore-based Nanyang Biologics (NYB), global digital infrastructure giant Equinix, and technology leader Hewlett Packard Enterprise (HPE) is capturing attention across the industry. This collaboration has given
In a landscape where medical research often progresses at a cautious pace, the Queen Elizabeth Hospital (QEH) has emerged as a trailblazer, setting a remarkable benchmark in the United Kingdom by achieving the extraordinary feat of becoming the fastest site in the UK to recruit 100 participants for
Imagine a future where a simple microbial profile from a tumor biopsy could predict a patient’s likelihood of surviving gastrointestinal (GI) cancer or responding to cutting-edge therapies. This isn’t science fiction—it’s a tangible possibility emerging from the intersection of microbiology and
What if a tiny fraction of people held the key to eradicating one of humanity's most persistent viruses, offering hope to the over 38 million individuals living with HIV worldwide? This virus has defied a universal cure for decades, yet in a handful of remarkable cases, some have walked away
In the rapidly evolving field of autoimmune disease treatment, Baricitinib, an oral Janus kinase (JAK) inhibitor, has carved out a significant role as a promising therapy for conditions such as rheumatoid arthritis and atopic dermatitis. For countless patients, particularly those in high-risk
